Decreased PHF8 leads to the enrichment of H3K9me2 in the promotor region of activating transcription factor 2 (ATF2) and permits its transcription, thereby inhibiting the proliferation of prostate cancer cells [79]. Here, PHF8 is linked to prostate carcinoma.